| Creon |
020725 |
005 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
36,000USP UNITS; 114,000USP UNITS; 180,000USP UNITS |
|
2013/03/14
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Kadcyla |
125427 |
001 |
351(a) |
ado-trastuzumab emtansine |
For Injection |
Intravenous |
100MG |
Single-Dose Vial |
2013/02/22
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Kadcyla |
125427 |
002 |
351(a) |
ado-trastuzumab emtansine |
For Injection |
Intravenous |
160MG |
Single-Dose Vial |
2013/02/22
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Privigen |
125201 |
005 |
351(a) |
Immune Globulin Intravenous (Human), 10% Liquid |
Injection |
Intravenous |
40G |
Single-Dose Vial |
2013/02/07
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Octaplas |
125416 |
001 |
351(a) |
Pooled Plasma (Human), Solvent/Detergent Treated |
For Injection |
Intravenous |
45-70MG/ML |
Bag |
2013/01/17
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Flublok |
125285 |
001 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
135UG/.5ML |
Single-Dose Vial |
2013/01/16
|
Protein Sciences Corporation |
Rx |
Licensed |
|
N/A |
| Rebif |
103780 |
004 |
351(a) |
interferon beta-1a |
Injection |
Subcutaneous |
8.8MCG/0.2ML |
Autoinjector |
2012/12/21
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Rebif |
103780 |
005 |
351(a) |
interferon beta-1a |
Injection |
Subcutaneous |
22MCG/0.5ML |
Autoinjector |
2012/12/21
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Rebif |
103780 |
006 |
351(a) |
interferon beta-1a |
Injection |
Subcutaneous |
44MCG/0.5ML |
Autoinjector |
2012/12/21
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Varizig |
125430 |
001 |
351(a) |
Varicella Zoster Immune Globulin (Human) |
For Injection |
Intramuscular |
125IU |
Vial |
2012/12/20
|
Kamada Ltd. |
Disc |
Licensed |
|
N/A |
| Bivigam |
125389 |
001 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5GM/50ML |
Vial |
2012/12/19
|
ADMA Biologics, Inc. |
Rx |
Licensed |
|
N/A |
| Bivigam |
125389 |
002 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10GM/100ML |
Vial |
2012/12/19
|
ADMA Biologics, Inc. |
Rx |
Licensed |
|
N/A |
| Fluarix, Fluarix Quadrivalent |
125127 |
002 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
60UG/.5ML |
Pre-Filled Syringe |
2012/12/14
|
GlaxoSmithKline Biologicals |
Disc |
Licensed |
|
N/A |
|
125349 |
001 |
351(a) |
raxibacumab |
Injection |
Intravenous |
1,700MG/34ML (50MG/ML) |
Single-Dose Vial |
2012/12/14
|
Emergent Manufacturing Operations Baltimore LLC |
Rx |
Licensed |
N/A |
N/A |
| Evarrest |
125392 |
001 |
351(a) |
Fibrin Sealant Patch |
Patch |
Topical |
50.3MG FIBRINOGEN&203.2IU THROMBIN/IN^2; 4x4 IN |
Pouch |
2012/12/05
|
Ethicon, Inc. |
Disc |
Licensed |
|
N/A |
| Flucelvax, Flucelvax Quadrivalent |
125408 |
001 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
45UG/.5ML |
Pre-Filled Syringe |
2012/11/20
|
Seqirus Inc. |
Disc |
Voluntarily Revoked |
|
N/A |
| Jetrea |
125422 |
002 |
351(a) |
ocriplasmin |
Injection |
Intravitreal |
0.5MG/0.2ML (2.5MG/ML) |
Single-Dose Vial |
2012/10/17
|
ThromboGenics Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Ducord |
125407 |
001 |
351(a) |
HPC, Cord Blood |
Injection |
Intravenous |
GREATER THAN OR EQUAL TO 2.5 X 10E7 PER KG CELLS PER KILOGRAM |
Bag |
2012/10/04
|
Duke University School of Medicine |
Rx |
Licensed |
|
N/A |
| Granix |
125294 |
001 |
351(a) |
tbo-filgrastim |
Injection |
Subcutaneous |
300MCG/0.5ML |
Pre-Filled Syringe |
2012/08/29
|
UAB Teva Baltics |
Rx |
Licensed |
N/A |
N/A |
| Granix |
125294 |
002 |
351(a) |
tbo-filgrastim |
Injection |
Subcutaneous |
480MCG/0.8ML |
Pre-Filled Syringe |
2012/08/29
|
UAB Teva Baltics |
Rx |
Licensed |
N/A |
N/A |